Central neurostimulatory therapies (device therapy)
An exciting development in the pain field that is being partially led by work in fibromyalgia (FM) is the explosion of interest and knowledge in the use of central neurostimulatory therapies in fibromyalgia and related conditions.[175]Mhalla A, Baudic S, Ciampi de Andrade D, et al. Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia. Pain. 2011 Jul;152(7):1478-85.
http://www.ncbi.nlm.nih.gov/pubmed/21397400?tool=bestpractice.com
[176]O'Connell NE, Marston L, Spencer S, et al. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev. 2018 Apr 13;(4):CD008208.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008208.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/29652088?tool=bestpractice.com
[
]
What are the effects of high‐frequency repetitive transcranial magnetic stimulation for people with chronic pain?/cca.html?targetUrl=https://www.cochranelibrary.com/cca/doi/10.1002/cca.2097/fullShow me the answer
[
]
What are the effects of multiple‐dose transcranial direct current stimulation for people with chronic pain?/cca.html?targetUrl=https://www.cochranelibrary.com/cca/doi/10.1002/cca.2098/fullShow me the answer These therapies, which include transcranial direct current stimulation and magnetic stimulation, may reduce pain and improve a number of other domains in fibromyalgia; in some cases, the effect of therapy has lasted well after the cessation of treatment.[177]Fagerlund AJ, Hansen OA, Aslaksen PM. Transcranial direct current stimulation as a treatment for patients with fibromyalgia: a randomized controlled trial. Pain. 2015 Jan;156(1):62-71.
http://www.ncbi.nlm.nih.gov/pubmed/25599302?tool=bestpractice.com
[178]Fregni F, El-Hagrassy MM, Pacheco-Barrios K, et al. Evidence-based guidelines and secondary meta-analysis for the use of transcranial direct current stimulation in neurological and psychiatric disorders. Int J Neuropsychopharmacol. 2021 Apr;24(4):256-313.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059493
http://www.ncbi.nlm.nih.gov/pubmed/32710772?tool=bestpractice.com
[179]Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014-2018). Clin Neurophysiol. 2020 Feb;131(2):474-528.
https://www.sciencedirect.com/science/article/pii/S1388245719312799?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/31901449?tool=bestpractice.com
[180]Lloyd DM, Wittkopf PG, Arendsen LJ, et al. Is transcranial direct current stimulation (tDCS) effective for the treatment of pain in fibromyalgia? A systematic review and meta-analysis. J Pain. 2020 Nov-Dec;21(11-12):1085-100.
https://www.jpain.org/article/S1526-5900(20)30004-3/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/31982685?tool=bestpractice.com
Further research is needed.
Low-dose naltrexone
When used at lower doses, naltrexone (an opioid antagonist) is thought to paradoxically decrease pain due to an increase in the release of endogenous opioids. It may also have anti-inflammatory properties. One systematic review concluded that low-dose naltrexone may be an alternative treatment for patients with chronic pain conditions.[181]Hatfield E, Phillips K, Swidan S, et al. Use of low-dose naltrexone in the management of chronic pain conditions: a systematic review. J Am Dent Assoc. 2020 Dec;151(12):891-902.e1.
http://www.ncbi.nlm.nih.gov/pubmed/33228882?tool=bestpractice.com
One small randomized, double blind, placebo-controlled, crossover trial included in the review specifically for fibromyalgia patients, reported that low-dose naltrexone significantly reduced pain compared with placebo.[182]Younger J, Noor N, McCue R, et al. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. 2013 Feb;65(2):529-38.
https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.37734
http://www.ncbi.nlm.nih.gov/pubmed/23359310?tool=bestpractice.com
Cannabinoids
Although there are no cannabinoids approved for use in chronic pain in the US, this class of drugs has displayed efficacy in both fibromyalgia and other chronic pain conditions.[183]Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011 Nov;72(5):735-44.
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2125.2011.03970.x
http://www.ncbi.nlm.nih.gov/pubmed/21426373?tool=bestpractice.com
Evidence from subsequent systematic reviews found insufficient, high-quality evidence of benefit for medical cannabis in patients with fibromyalgia; however, emerging data suggest a positive effect.[184]Walitt B, Klose P, Fitzcharles MA, et al. Cannabinoids for fibromyalgia. Cochrane Database Syst Rev. 2016 Jul 18;(7):CD011694.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011694.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/27428009?tool=bestpractice.com
[185]Fitzcharles MA, Niaki OZ, Hauser W, et al. Position statement: a pragmatic approach for medical cannabis and patients with rheumatic diseases. J Rheumatol. 2019 May;46(5):532-8.
https://www.jrheum.org/content/46/5/532.long
http://www.ncbi.nlm.nih.gov/pubmed/30647183?tool=bestpractice.com
[186]Berger AA, Keefe J, Winnick A, et al. Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia. Best Pract Res Clin Anaesthesiol. 2020 Sep;34(3):617-31.
http://www.ncbi.nlm.nih.gov/pubmed/33004171?tool=bestpractice.com
[187]Guillouard M, Authier N, Pereira B, et al. Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis. Rheumatology (Oxford). 2021 Feb;60(2):549-56.
https://academic.oup.com/rheumatology/article/60/2/549/5960204?login=false
http://www.ncbi.nlm.nih.gov/pubmed/33159797?tool=bestpractice.com
There is uncertainty regarding the optimal dose and ideal cannabidiol (CBD)/tetrahydrocannabinol (THC) ratios.
Ketamine infusions
In addition to the serotoninergic and noradrenergic neurotransmitter systems, the glutaminergic system is also clearly involved in fibromyalgia and more broadly in pain sensation, as evidenced by the fact that an intravenous ketamine infusion seems to be predictive of subsequent responsiveness to dextromethorphan in fibromyalgia but is not efficacious itself as long-term therapy.[188]Cohen SP, Verdolin MH, Chang AS, et al. The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. J Pain. 2006 Jun;7(6):391-8.
http://www.ncbi.nlm.nih.gov/pubmed/16750795?tool=bestpractice.com
Memantine
The efficacy of memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is being assessed for the treatment of chronic pain in patients with FM. One systematic review reports that evidence regarding the use of memantine for chronic pain is limited and uncertain.[189]Kurian R, Raza K, Shanthanna H. A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain. Eur J Pain. 2019 Aug;23(7):1234-50.
https://onlinelibrary.wiley.com/doi/10.1002/ejp.1393
http://www.ncbi.nlm.nih.gov/pubmed/30848504?tool=bestpractice.com
Despite its potential, pain relief achieved in clinical studies is small and is associated with an increase in dizziness; therefore, no clear recommendations can be made about its routine clinical use until larger and more definitive studies are conducted.[189]Kurian R, Raza K, Shanthanna H. A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain. Eur J Pain. 2019 Aug;23(7):1234-50.
https://onlinelibrary.wiley.com/doi/10.1002/ejp.1393
http://www.ncbi.nlm.nih.gov/pubmed/30848504?tool=bestpractice.com
Selective serotonin-reuptake inhibitors (SSRIs)
Studies have found varying effects of SSRIs on pain in patients with FM, suggesting that the benefits of selective-norepinephrine reuptake inhibitors (SNRIs) might be derived from the increased norepinephrine rather than serotonin. SSRIs are not recommended for treatment of pain, sleep disturbance, or fatigue in the EULAR guidelines.There have, however, been reports that using an SSRI together with a tricyclic antidepressant can be helpful in fibromyalgia.[147]Goldenberg D, Mayskiy M, Mossey C, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996 Nov;39(11):1852-9.
http://www.ncbi.nlm.nih.gov/pubmed/8912507?tool=bestpractice.com
Esreboxetine
A highly selective norepinephrine reuptake inhibitor that has been studied in preclinical pain models and is being investigated for use in fibromyalgia. A blinded, placebo-controlled study of 267 patients showed that the esreboxetine group had statistically significant improvement compared with placebo with respect to weekly average pain, and that more patients in the treatment group reported a >30% pain reduction (37.6% vs. 22.4%). Improvements were also seen in quality of life and functional measures.[190]Arnold LM, Chatamra K, Hirsch I, et al. Safety and efficacy of esreboxetine in patients with fibromyalgia: an 8-week, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther. 2010 Aug;32(9):1618-32.
http://www.ncbi.nlm.nih.gov/pubmed/20974319?tool=bestpractice.com
Mirtazapine
Mirtazapine, a tetracyclic antidepressant, has been demonstrated a clinically relevant reduction in pain (30% or greater), reduction of mean pain intensity, and sleep problems compared with placebo in adults with fibromyalgia.[191]Welsch P, Bernardy K, Derry S, et al. Mirtazapine for fibromyalgia in adults. Cochrane Database Syst Rev. 2018 Aug;8(8):CD012708.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513659
http://www.ncbi.nlm.nih.gov/pubmed/30080242?tool=bestpractice.com
Somnolence, weight gain, and elevated alanine aminotransferase were more frequent with mirtazapine than placebo.[191]Welsch P, Bernardy K, Derry S, et al. Mirtazapine for fibromyalgia in adults. Cochrane Database Syst Rev. 2018 Aug;8(8):CD012708.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513659
http://www.ncbi.nlm.nih.gov/pubmed/30080242?tool=bestpractice.com
Melatonin
Melatonin, a neurohormone, has been shown to have several positive effects on patients with FM, including improvement of sleep quality, pain, and disease impact.[192]Hemati K, Amini Kadijani A, Sayehmiri F, et al. Melatonin in the treatment of fibromyalgia symptoms: a systematic review. Complement Ther Clin Pract. 2020 Feb;38:101072.
https://www.sciencedirect.com/science/article/abs/pii/S1744388119308059?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/31783341?tool=bestpractice.com
Compared with other agents such as duloxetine, no major adverse events were reported following treatment with melatonin consumption.[192]Hemati K, Amini Kadijani A, Sayehmiri F, et al. Melatonin in the treatment of fibromyalgia symptoms: a systematic review. Complement Ther Clin Pract. 2020 Feb;38:101072.
https://www.sciencedirect.com/science/article/abs/pii/S1744388119308059?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/31783341?tool=bestpractice.com
Further research is needed
Transcutaneous electrical nerve stimulation (TENS)
One Cochrane review concluded that there is insufficient high-quality evidence to support or refute the use of transcutaneous electrical nerve stimulation (TENS) for fibromyalgia.[193]Johnson MI, Claydon LS, Herbison GP, et al. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Cochrane Database Syst Rev. 2017 Oct 9;(10):CD012172.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012172.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/28990665?tool=bestpractice.com
One subsequent randomized controlled trial (RCT) reported that in women with fibromyalgia who were on a stable medication regimen, 4 weeks of active TENS significantly improved movement evoked pain compared with placebo TENS or no TENS.[194]Dailey DL, Vance CGT, Rakel BA, et al. Transcutaneous electrical nerve stimulation reduces movement-evoked pain and fatigue: a randomized, controlled trial. Arthritis Rheumatol. 2020 May;72(5):824-36.
https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.41170
http://www.ncbi.nlm.nih.gov/pubmed/31738014?tool=bestpractice.com
Vagus nerve stimulation (VNS)
One phase 1/2 proof of concept trial in patients with treatment refractory fibromyalgia reported that of the 12 patients that completed the trial, five patients achieved the efficacy measure (a composite measure; reduction in pain, improvement of overall wellness, and physical function) at 3 months, with two patients attaining the secondary outcome of no longer experiencing the widespread pain or tenderness criteria necessary for the diagnosis of fibromyalgia.[195]Lange G, Janal MN, Maniker A, et al. Safety and efficacy of vagus nerve stimulation in fibromyalgia: a phase I/II proof of concept trial. Pain Med. 2011 Sep;12(9):1406-13.
https://academic.oup.com/painmedicine/article/12/9/1406/1899449?login=false
http://www.ncbi.nlm.nih.gov/pubmed/21812908?tool=bestpractice.com
The effect appeared to increase over time, with additional patients attaining both criteria at 11 months.
Acupuncture
A review of randomized trials of traditional Chinese medicine (TCM) treatment for fibromyalgia (including not only acupuncture but also TCM modalities of herbal medication and cupping) suggested that these therapies seem to be effective, but trials are limited by insufficient methodologic rigor.[196]Cao H, Liu J, Lewith GT. Traditional Chinese Medicine for treatment of fibromyalgia: a systematic review of randomized controlled trials. J Altern Complement Med. 2010 Apr;16(4):397-409.
http://www.ncbi.nlm.nih.gov/pubmed/20423209?tool=bestpractice.com
A subsequent systematic review reported that invasive techniques (including acupuncture and dry needling) significantly decreased pain, improved the pain pressure threshold and quality of life.[197]Sarmiento-Hernández I, Pérez-Marín MLÁ, Nunez-Nagy S, et al. Effectiveness of invasive techniques in patients with fibromyalgia: systematic review and meta-analysis. Pain Med. 2020 Dec;21(12):3499-511.
https://academic.oup.com/painmedicine/article/21/12/3499/5957443?login=false
http://www.ncbi.nlm.nih.gov/pubmed/33156331?tool=bestpractice.com
One Cochrane review found that the use of electroacupuncture might be more effective than manual acupuncture (not involving electrostimulation).[198]Deare JC, Zheng Z, Xue CC, et al. Acupuncture for treating fibromyalgia. Cochrane Database Syst Rev. 2013 May;2013(5):CD007070.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105202
http://www.ncbi.nlm.nih.gov/pubmed/23728665?tool=bestpractice.com
Biofeedback
Derangement of the autonomic nervous system has been proposed to account for some of the symptomatology in patients with fibromyalgia. Heart rate variability (HRV) biofeedback training, which teaches the patient to breathe at a resonant frequency, can help decrease sympathetic overdrive and perhaps reduce pain. There is a very small amount of evidence to suggest that there was decrease in pain and depression and increase in functioning after 10 weekly sessions of HRV biofeedback training.[199]Radvanski DC, Vaschillo EG, Vaschillo B, et al. A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia. App Psychophys Biofeedback. 2007 Mar;32(1):1-10.
http://www.ncbi.nlm.nih.gov/pubmed/17219062?tool=bestpractice.com
Electromyography (EMG) biofeedback has been shown to be modestly helpful in decreasing pain in a small study of poor design.[200]Babu AS, Mathew E, Danda D, et al. Management of patients with fibromyalgia using biofeedback: a randomized control trial. Indian J Med Sci. 2007 Aug;61(8):455-61.
http://www.ncbi.nlm.nih.gov/pubmed/17679735?tool=bestpractice.com
Further research is warranted.
Herbal/supplement medications
Some evidence suggests potential benefit from magnesium, L-carnitine, coenzyme Q10, and S-adenosylmethionine, although firm conclusions cannot yet be drawn on the benefits of these or other supplements.[201]Porter NS, Jason LA, Boulton A, et al. Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia. J Altern Complement Med. 2010 Mar;16(3):235-49.
http://www.ncbi.nlm.nih.gov/pubmed/20192908?tool=bestpractice.com
[202]Ferreira I, Ortigoza Á, Moore P. Magnesium and malic acid supplement for fibromyalgia. [in spa]. Medwave. 2019 May;19(4):e7633.
http://www.ncbi.nlm.nih.gov/pubmed/31150373?tool=bestpractice.com
[203]Mehrabani S, Askari G, Miraghajani M, et al. Effect of coenzyme Q10 supplementation on fatigue: a systematic review of interventional studies. Complement Ther Med. 2019 Apr;43:181-7.
https://www.sciencedirect.com/science/article/abs/pii/S0965229918311506?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/30935528?tool=bestpractice.com
Homeopathy
One systematic review of trials on homoeopathy for symptom reduction in fibromyalgia found three placebo-controlled randomized controlled trials that suggested benefit from the use of homeopathy, although more research is needed.[204]Perry R, Terry R, Ernst E. A systematic review of homoeopathy for the treatment of fibromyalgia. Clin Rheumatol. 2010 May;29(5):457-64.
http://www.ncbi.nlm.nih.gov/pubmed/20099019?tool=bestpractice.com
Hydrotherapy
More commonly used in European countries, hydrotherapy, or the use of water for therapeutic purposes, has been studied for fibromyalgia in small trials. Balneotherapy (bathing in warm or cold medicinal water or mud) or spa therapy (bathing in mineral water) are forms of hydrotherapy. A meta-analysis found studies of hydrotherapy in fibromyalgia to be of small size and poor quality, but suggested that hydrotherapy may result in modest short-term reductions in pain for patients with fibromyalgia.[205]Langhorst J, Musial F, Klose P, et al. Efficacy of hydrotherapy in fibromyalgia syndrome - a meta-analysis of randomized controlled clinical trials. Rheumatology (Oxford). 2009 Sep;48(9):1155-9.
http://www.ncbi.nlm.nih.gov/pubmed/19608724?tool=bestpractice.com
A further review of hydrology treatment concluded that evidence is limited and further clinical trials are needed for each relevant application.[206]Antonelli M, Donelli D, Veronesi L, et al. Clinical efficacy of medical hydrology: an umbrella review. Int J Biometeorol. 2021 Oct;65(10):1597-614.
http://www.ncbi.nlm.nih.gov/pubmed/33866427?tool=bestpractice.com
Manual therapies
There is moderate evidence for massage therapy and limited evidence of poor quality for spinal manipulation to help patients with fibromyalgia.[207]Schneider M, Vernon H, Ko G, et al. Chiropractic management of fibromyalgia syndrome: a systematic review of the literature. J Manipulative Physiol Ther. 2009 Jan;32(1):25-40.
http://www.ncbi.nlm.nih.gov/pubmed/19121462?tool=bestpractice.com
[208]Bronfort GH, Haas M, Evans R, et al. Effectiveness of manual therapies: the UK evidence report. Chiroprac Osteopat. 2010 Feb 25;18:3.
https://chiromt.biomedcentral.com/articles/10.1186/1746-1340-18-3
http://www.ncbi.nlm.nih.gov/pubmed/20184717?tool=bestpractice.com
[209]Kalichman L. Massage therapy for fibromyalgia symptoms. Rheumatol Int. 2010 Jul;30(9):1151-7.
http://www.ncbi.nlm.nih.gov/pubmed/20306046?tool=bestpractice.com
[210]Ernst E. Chiropractic treatment for fibromyalgia: a systematic review. Clin Rheumatol. 2009 Oct;28(10):1175-8.
http://www.ncbi.nlm.nih.gov/pubmed/19544042?tool=bestpractice.com
Qi Gong
Qi Gong is a martial art therapy that is part of traditional Chinese medicine. Little evidence is available, but in one study patients demonstrated dramatic reductions in pain and improvements in functioning.[211]Chen KW, Hassett AL, Hou F, et al. A pilot study of external qigong therapy for patients with fibromyalgia. J Altern Complement Med. 2006 Nov;12(9):851-6.
http://www.ncbi.nlm.nih.gov/pubmed/17109575?tool=bestpractice.com